353C Route 46, Suite 250 , Fairfield, NJ, 07004
PIN#81622S0003001
The purpose of this contract is to procure sole source assay kits, reagents, equipment (including service and maintenance), instruments and other supplies from Vela to conduct HIV-1 genome sequencing and testing. Specifically, the FDA-approved Sentosa SQ HIV Genotyping Assay which uses next generation sequencing technology to accurately detect HIV-1 genotypes and Drug Resistance Mutations in the Integrase, Protease & Reverse Transcriptase regions of the pol gene. Compared with traditional methods for HIV genotyping, this NGS-based assay delivers results in days, while identifying DRMs with greater sensitivity. The items and instruments can only be purchased from Vela and cannot be purchased from any other vendor. These items are necessary to get a better understanding and more efficiently conduct HIV genotyping in the city and around the globe. No other products of this type can meet the needs of the laboratory, especially relating to the sequencing of HIV-1 genotypes.
